MLK4 (also known as MAP3K21/KIAA1804) is a member of the mixed lineage kinase (MLK) family of serine/threonine kinases that function as MAP3Ks. MLK4 plays critical roles in regulating multiple MAPK signaling pathways, including:
JNK (c-Jun N-terminal kinase) pathway
p38 MAPK pathway
ERK (extracellular signal-regulated kinase) pathway
Unlike other MLK family members that typically activate these pathways, MLK4β has been shown to negatively regulate MAPK activities, acting as a suppressor of MLK3 activation and cell invasion . MLK4 is expressed in various tissues and cell types, with distinct localization patterns including cytoplasmic, membrane, and nuclear distribution depending on cell type .
MLK4 exists in at least two confirmed isoforms:
MLK4α: Contains unique C-terminal sequences
MLK4β: Features distinct structural characteristics affecting function
When selecting antibodies, researchers should note that some antibodies specifically target MLK4α. For example, R&D Systems' AF3435 antibody detects "endogenous human, mouse, and rat MLK4 alpha" because the "peptide immunogen corresponds to a region at the C-terminus of MLK4 alpha absent in MLK4 beta" . For comprehensive MLK4 studies, researchers should verify which isoform(s) their selected antibody detects.
MLK4 antibodies are employed in multiple experimental techniques:
| Application | Recommended Dilution | Notes |
|---|---|---|
| Western Blot | 0.04-0.4 μg/ml | Detects bands at approximately 62 kDa (MLK4α) or 114 kDa (full-length) |
| Immunohistochemistry (IHC) | 1:50-1:200 | HIER pH 6 retrieval recommended for paraffin sections |
| Immunocytochemistry (ICC) | 0.25-2 μg/ml | PFA/Triton X-100 fixation/permeabilization recommended |
| Immunoprecipitation (IP) | 3 μg/mg lysate | Effective for protein complex analysis |
Note that optimal dilutions should be determined empirically for each application and antibody .
Proper validation is essential before using MLK4 antibodies for critical experiments:
Positive Controls: Use cell lines with known MLK4 expression (validated examples include K562, Ramos, HeLa, and 293T)
Knockdown Validation: Conduct siRNA experiments to demonstrate specificity. The search results describe validated sequences:
Multiple Antibody Approach: Use antibodies targeting different epitopes to confirm findings
Tissue Expression Pattern: Verify expected localization patterns. For example, MLK4 shows "strong cytoplasmic positivity in Purkinje cells" in cerebellum and "localization to plasma membrane & cytosol" in A-431 cells .
For optimal immunohistochemical detection of MLK4 in paraffin-embedded tissues:
Section Preparation:
Cut paraffin sections at 4 μm thickness
Deparaffinize at 70°C for 90 minutes
Antigen Retrieval:
Block endogenous peroxidase with 3% H₂O₂ for 5-10 minutes
For paraffin sections, heat-induced epitope retrieval (HIER) at pH 6 is recommended
Blocking and Primary Antibody Incubation:
Block with 5% BSA for 20 minutes at room temperature
Incubate with primary antibody (e.g., anti-MLK4 antibody at 1:200 dilution) overnight at 4°C
Detection System:
Analysis:
Common issues and solutions:
| Issue | Potential Causes | Recommended Solutions |
|---|---|---|
| Weak Signal | Insufficient antigen retrieval | Optimize retrieval conditions (time, pH, temperature) |
| Low antibody concentration | Titrate antibody concentrations | |
| Degraded epitope | Use fresh samples or different fixation methods | |
| Non-specific Staining | Inadequate blocking | Increase blocking time/concentration |
| Cross-reactivity | Try antibodies targeting different epitopes | |
| Secondary antibody issues | Include secondary-only controls | |
| Background | Endogenous peroxidase activity | Extend H₂O₂ blocking time |
| Overfixation | Optimize fixation protocol |
MLK4 has been implicated in multiple cancer types with context-dependent functions. To study its role:
Expression Analysis in Clinical Samples:
Functional Studies in Cancer Cell Lines:
Signaling Pathway Analysis:
Invasion and Migration Assays:
MLK4 mutations are found in multiple cancers including colorectal cancer (7% frequency). To investigate their effects:
Mutation Characterization Pipeline:
Identify mutations of interest from databases (TCGA, COSMIC)
Create expression constructs for wild-type and mutant MLK4
Express in appropriate cell systems
Use antibodies to verify expression levels
Assess kinase activity with in vitro assays
Functional Assessment of Mutations:
Rescue Experiments:
Recent research has uncovered MLK4's role in cellular metabolism, particularly in cancer:
Metabolic Pathway Analysis:
Use MLK4 antibodies in combination with metabolic enzyme antibodies
Investigate relationships between MLK4 expression and metabolic markers
Example finding: "MLK4 knockdown led to significant reduction of glycolysis and decreased levels of glycolytic pathway metabolites including phosphoenolpyruvate and lactate"
Transcriptional Regulation Studies:
Integrated Approach:
Recent studies show MLK4 has significant immunological functions:
Immune Cell Analysis:
Cytokine Expression Studies:
Immune Checkpoint Correlation:
Bioinformatic Analysis Pipeline:
To maintain antibody quality and performance:
Storage Recommendations:
Working Solution Preparation:
Quality Control:
Include appropriate positive controls with each experiment
Consider time-dependent degradation of antibody performance
Validate new lots against previous results
The choice of epitope target significantly impacts experimental outcomes:
Epitope Considerations:
Recommended Approach:
For isoform-specific analysis: Use antibodies with verified specificity
For total MLK4 detection: Use antibodies targeting conserved regions
For phosphorylation studies: Use phospho-specific antibodies
Application-Specific Selection:
For structural studies: Select antibodies against accessible epitopes
For functional studies: Choose antibodies that don't interfere with protein activity
For interaction studies: Avoid antibodies targeting binding domains